Brighton Jones LLC Adaptive Biotechnologies Corp Transaction History

Brighton Jones LLC

$2.55 Billion
Q3 2024

A detailed history of Brighton Jones LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Brighton Jones LLC holds 24,289 shares of ADPT stock, worth $113,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,289

Previous 25,289 3.95%

Holding current value

$113,915

Previous $91,000 36.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$3.37 - $5.12 $3,370 - $5,120	-1,000 Reduced 3.95%	24,289 $124,000
Q2 2024 Aug 12, 2024	SELL	$2.34 - $3.96 $2,808 - $4,752	-1,200 Reduced 4.53%	25,289 $91,000
Q1 2024 May 09, 2024	BUY	$2.88 - $4.8 $1,739 - $2,899	604 Added 2.33%	26,489 $85,000
Q4 2023 Feb 05, 2024	SELL	$3.46 - $5.33 $51,536 - $79,390	-14,895 Reduced 36.53%	25,885 $126,000
Q3 2023 Oct 25, 2023	BUY	$5.07 - $8.44 $1,130 - $1,882	223 Added 0.55%	40,780 $222,000
Q2 2023 Jul 31, 2023	BUY	$6.19 - $8.78 $3,361 - $4,767	543 Added 1.36%	40,557 $272,000
Q1 2023 May 08, 2023	BUY	$7.8 - $10.11 $111,251 - $144,198	14,263 Added 55.39%	40,014 $353,000
Q4 2022 Feb 02, 2023	SELL	$6.26 - $9.34 $50,749 - $75,719	-8,107 Reduced 23.94%	25,751 $196,000
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $3,276 - $6,385	504 Added 1.51%	33,858 $241,000
Q2 2022 Aug 04, 2022	BUY	$6.4 - $14.73 $2,252 - $5,184	352 Added 1.07%	33,354 $270,000
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $42,453 - $121,235	-4,195 Reduced 11.28%	33,002 $458,000
Q4 2021 Feb 03, 2022	SELL	$25.17 - $36.85 $200,655 - $293,768	-7,972 Reduced 17.65%	37,197 $1.04 Million
Q3 2021 Nov 04, 2021	BUY	$30.02 - $39.87 $810 - $1,076	27 Added 0.06%	45,169 $1.54 Million
Q2 2021 Aug 10, 2021	SELL	$32.22 - $44.59 $9,827 - $13,599	-305 Reduced 0.67%	45,142 $1.85 Million
Q1 2021 May 07, 2021	SELL	$37.26 - $67.74 $55,331 - $100,593	-1,485 Reduced 3.16%	45,447 $1.83 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $14,137 - $19,279	395 Added 0.85%	46,932 $2.28 Million
Q2 2020 Aug 11, 2020	SELL	$24.95 - $48.38 $184,854 - $358,447	-7,409 Reduced 13.73%	46,537 $2.25 Million
Q1 2020 May 13, 2020	BUY	$16.96 - $34.16 $914,924 - $1.84 Million	53,946 New	53,946 $1.5 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Account

Brighton Jones LLC Adaptive Biotechnologies Corp Transaction History